<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00796328</url>
  </required_header>
  <id_info>
    <org_study_id>IWK-4462-2008</org_study_id>
    <nct_id>NCT00796328</nct_id>
  </id_info>
  <brief_title>Up-Down Determination of the ED90 of Phenylephrine for Hypotension Prophylaxis in Cesarean Delivery</brief_title>
  <official_title>Up-down Determination of the ED90 of the Initial Rate of Infusion of Phenylephrine for the Prophylaxis of Spinal Induced Hypotension in Parturients Undergoing Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IWK Health Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine the ED90 for an infusion of phenylephrine to prevent
      spinal induced low blood pressure in parturients presenting for an elective cesarean
      delivery. The up-down methodology (UDM) is commonly used study method to determine the dose
      of a drug that causes the desired effect in over 90% of the subjects to whom it given. For
      example: the investigators want to know what is the best dose of phenylephrine (from a range
      of commonly used doses) to prevent a drop in blood pressure during cesarean delivery ninety
      times out of one hundred when it is given at that dose. The ED90 is the effective dose at
      which 90% of subjects will have a &quot;positive&quot; response to a phenylephrine infusion, i.e. no
      drop in blood pressure. The investigators hypothesize that the ED90 will be between 40 - 60
      mcg/min.

      The primary outcome measure is the ED90 for phenylephrine infusions that prevents a drop in
      blood pressure in women undergoing cesarean delivery.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Results Invalid, study closed, analysis cannot proceed.
  </why_stopped>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective Dose of Phenylephrine at Which 90% of Subjects Have no Spinal Induced Hypotension</measure>
    <time_frame>Spinal administration until delivery</time_frame>
    <description>The effective dose at which 90% of subjects will have a &quot;positive&quot; response to a phenylephrine infusion, i.e. no spinal induced hypotension. We hypothesize that the ED90 will be between 40 - 60 mcg/min.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Spinal Induced Hypotension in Cesarean Delivery</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine infusion</intervention_name>
    <description>Up-down, biased coin design</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Non-emergent cesarean delivery with planned spinal anesthesia (i.e. elective planned
             cesarean delivery for malposition, patient choice, cervical pelvic disproportion,
             previous cesarean delivery and other diagnosis that require a predetermined cesarean
             delivery)

          2. American Society of Anesthesia physical status class I &amp; II (ASA I - Healthy, ASA II -
             mild and controlled systemic disease, eg. controlled essential hypertension)

          3. Age ≥ 18 years (Standard within the obstetrical literature)

          4. Term gestational age

          5. English-speaking

        Exclusion Criteria:

          1. Morbid Obesity (Body Mass Index ≥ 45 kg/m2) (Morbidly obese parturients require a dose
             of local anesthetic less than the standardized dose in this study, typically have an
             exaggerated response to vasopressors, and the blood pressure cuff occasionally needs
             to be replaced by an intra-arterial catheter due to limitations in size)

          2. Height &lt; 5'0&quot; (Women &lt; 5'0&quot; are likely to require a dose of local anesthetic less than
             the standardized dose in this study)

          3. Laboring women

          4. Urgent or emergency cesarean delivery

          5. Hypertensive disease of pregnancy

          6. Severe maternal cardiac disease

          7. Subjects on monoamine oxidase inhibitors (MAOI's) or tricyclic antidepressants

          8. Fetal anomalies or intrauterine fetal death

          9. Failed spinal anesthesia

         10. Subject enrollment in another study involving a study medication within 30 days of CD

         11. Any other physical or psychiatric condition which may impair their ability to
             cooperate with study data collection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2008</study_first_submitted>
  <study_first_submitted_qc>November 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2008</study_first_posted>
  <results_first_submitted>March 14, 2014</results_first_submitted>
  <results_first_submitted_qc>March 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 21, 2014</results_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IWK Health Centre</investigator_affiliation>
    <investigator_full_name>Ronald George</investigator_full_name>
    <investigator_title>Primary Investigator, MD, FRCPC, Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Six subjects were withdrawn from the study</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Phenylephrine Infusion</title>
          <description>Phenylephrine infusion : Up-down, biased coin design</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>experienced hypotension requiring tx</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Phenylephrine Infusion</title>
          <description>Phenylephrine infusion : Up-down, biased coin design</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effective Dose of Phenylephrine at Which 90% of Subjects Have no Spinal Induced Hypotension</title>
        <description>The effective dose at which 90% of subjects will have a “positive” response to a phenylephrine infusion, i.e. no spinal induced hypotension. We hypothesize that the ED90 will be between 40 – 60 mcg/min.</description>
        <time_frame>Spinal administration until delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Infusion</title>
            <description>Phenylephrine infusion : Up-down, biased coin design</description>
          </group>
        </group_list>
        <measure>
          <title>Effective Dose of Phenylephrine at Which 90% of Subjects Have no Spinal Induced Hypotension</title>
          <description>The effective dose at which 90% of subjects will have a “positive” response to a phenylephrine infusion, i.e. no spinal induced hypotension. We hypothesize that the ED90 will be between 40 – 60 mcg/min.</description>
          <units>dose of phenylephrine</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">An error in the up-down sequencing was discovered. The subsequent participants would have allocated to a dose incorrectly as per the biased coin design. The results are invalid.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Phenylephrine Infusion</title>
          <description>Phenylephrine infusion : Up-down, biased coin design</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ron George</name_or_title>
      <organization>IWK Health Centre</organization>
      <phone>470-6627</phone>
      <email>rbgeorge@dal.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

